Divi's Laboratories Limited — research summary

Price history, fundamentals, business-quality scores, DCF intrinsic value, shareholding, quarterly results and risk metrics for Divi's Laboratories Limited, explained in plain English.

• ▪Divi's Laboratories Limited is tracked in the Pharma & Healthcare sector of our NSE large-cap universe.
• ▪Reported fundamentals show a net margin of 26.05%, debt to equity of 0.04.
• ▪Our transparent MaxGrade checklist scores it A (81/100) across momentum, growth, profitability and safety, using Pharma & Healthcare sector medians as the bar.
• ▪Annualised volatility over the past year is 23.62% with a maximum drawdown of -15.44% and a beta of 0.63 against NIFTY 50.
• ▪Recent coverage: Divi's Labs, TVS Motor could replace Max Healthcare, HDFC Life in Nifty 2027 index review
• ▪Recent coverage: Top 3 stocks to buy or sell tomorrow: Divis Lab, MCX, Maruti Suzuki by Chandan Taparia - Check stop-loss, targets

Figures from the current session. Market open.